Waqar Waheed

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

James F. Howard, Kimiaki Utsugisawa, Michael Benatar et al. · The Lancet Neurology · 2017 · 745 citations

Multicentre Study, Pharmacology, Medicine +3

Current treatment practice of Guillain-Barré syndrome

Christine Verboon, Alex Y. Doets, Giuliana Galassi et al. · Neurology · 2019 · 87 citations · Full text

An International Perspective on Preceding Infections in Guillain-Barré Syndrome

Sonja E. Leonhard, Annemiek A. van der Eijk, Henning Andersen et al. · Neurology · 2022 · 76 citations · Full text

Post-intervention Status in Patients With Refractory Myasthenia Gravis Treated With Eculizumab During REGAIN and Its Open-Label Extension

Renato Mantegazza, Gil I. Wolfe, Srikanth Muppidi et al. · Neurology · 2020 · 74 citations · Full text

Guillain-Barré syndrome after SARS-CoV-2 infection in an international prospective cohort study

Linda W.G. Luijten, Sonja E. Leonhard, Annemiek A. van der Eijk et al. · Brain · 2021 · 72 citations · Full text

Recruitment Bias, World Health Organization, Long Covid +12